Walking for Metabolic Disturbances

Phase-Based Progress Estimates
University of Toronto, Toronto, Canada
Metabolic Disturbances
Bodyweight interval exercise - Behavioral
What conditions do you have?

Study Summary

This study will determine how different at-home exercise strategies influence 24hr glycemic control in women with metabolic dysfunction.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Metabolic Disturbances

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: 15-30 minutes

15-30 minutes
Change in glucose during exercise
2 hours
Postprandial breakfast glucose response
Postprandial dinner glucose response
Postprandial lunch glucose response
24 hours
% coefficient of variation (CV)
24hr Average glucose concentration
24hr Glucose area under the curve
Continuous overall net glycemic action (CONGA)
Mean amplitude glycemic excursion (MAGE)
Standard deviation (SD)
Time in hyperglycemia
Time in hypoglycemia
Time in range
~6-8 hours
Nocturnal glucose

Trial Safety

Safety Progress

1 of 3

Other trials for Metabolic Disturbances

Trial Design

3 Treatment Groups

Non exercise control
1 of 3
1 of 3
Bodyweight interval exercise
1 of 3
Active Control
Experimental Treatment

50 Total Participants · 3 Treatment Groups

Primary Treatment: Walking · No Placebo Group · N/A

Experimental Group · 1 Intervention: Walking · Intervention Types: Behavioral
Bodyweight interval exercise
Experimental Group · 1 Intervention: Bodyweight interval exercise · Intervention Types: Behavioral
Non exercise controlNoIntervention Group · 1 Intervention: Non exercise control · Intervention Types:
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 2

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 15-30 minutes

Trial Background

Prof. Jenna Gillen, Assistant Professor
Principal Investigator
University of Toronto
Closest Location: University of Toronto · Toronto, Canada
Photo of Toronto  1Photo of Toronto  2Photo of Toronto  3
2007First Recorded Clinical Trial
1 TrialsResearching Metabolic Disturbances
107 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Female Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are 50 years of age or older.
You own a smartphone with Bluetooth capability with Apple or Android operating system.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.